Novo Nordisk's Shares Go on a Rollercoaster Ride After Earnings
Novo Nordisk A/S TodayNVONovo Nordisk A/S86.96▼145.17Add to WatchlistNovo Nordisk NYSE: NVO is the world’s second-largest pharmaceutical company, with a market capitalization of $538 billion. The Danish firm’s shares have performed well so far in 2024, returning 23%, outperforming its sector. The iShares Global Healthcare ETF NYSEARCA: IXJ has returned 11%.The firm's standout performance largely stems from its successf ...